GenBio AI
PrivateLast Round
Series A
Jun 24, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GenBio AI is a biotechnology company that develops AI-driven multiscale foundation models to simulate, predict, and program biological systems for drug discovery and biomedical research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI, Synthetic Data
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenBio AI Comparables
Compare GenBio AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noetik | 86% | |
| CellType | 85% | |
| EvolutionaryScale | 83% | |
GenBio AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 24, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2026
Grew 28% QoQ, from 53 to 68 employees.
- Jun 24, 2026
Grew 24% QoQ, from 49 to 61 employees.
GenBio AI Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GenBio AI's valuation, stock price, and market status.